201 related articles for article (PubMed ID: 38324215)
21. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
[TBL] [Abstract][Full Text] [Related]
22. Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
Schadt L; Sparano C; Schweiger NA; Silina K; Cecconi V; Lucchiari G; Yagita H; Guggisberg E; Saba S; Nascakova Z; Barchet W; van den Broek M
Cell Rep; 2019 Oct; 29(5):1236-1248.e7. PubMed ID: 31665636
[TBL] [Abstract][Full Text] [Related]
23. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
Ueki S; Fujishima F; Kumagai T; Ishida H; Okamoto H; Takaya K; Sato C; Taniyma Y; Kamei T; Sasano H
BMC Cancer; 2020 Feb; 20(1):161. PubMed ID: 32106831
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
[TBL] [Abstract][Full Text] [Related]
25. [Expression of the cGAS-STING Pathway in dMMR/MSI-H in Colorectal Cancer].
Kaneta A; Nakajima S; Mimura K; Kono K
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1130-1132. PubMed ID: 36281609
[TBL] [Abstract][Full Text] [Related]
26. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Mekers VE; Kho VM; Ansems M; Adema GJ
Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
[TBL] [Abstract][Full Text] [Related]
27. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING.
Tian J; Zhang D; Kurbatov V; Wang Q; Wang Y; Fang D; Wu L; Bosenberg M; Muzumdar MD; Khan S; Lu Q; Yan Q; Lu J
EMBO J; 2021 Apr; 40(7):e106065. PubMed ID: 33615517
[TBL] [Abstract][Full Text] [Related]
28. FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS-STING pathway activation.
Wu Y; Lin Y; Shen F; Huang R; Zhang Z; Zhou M; Fang Y; Shen J; Fan X
Neoplasia; 2024 Mar; 49():100973. PubMed ID: 38277817
[TBL] [Abstract][Full Text] [Related]
29. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma.
Zhu C; Li J; Yao M; Fang C
BMC Oral Health; 2021 Oct; 21(1):506. PubMed ID: 34625078
[TBL] [Abstract][Full Text] [Related]
30. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract][Full Text] [Related]
31. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
Shen Q; Xu P; Mei C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
[TBL] [Abstract][Full Text] [Related]
32. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
Pépin G; Gantier MP
Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
[TBL] [Abstract][Full Text] [Related]
33. Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway.
Li Y; Chen H; Yang Q; Wan L; Zhao J; Wu Y; Wang J; Yang Y; Niu M; Liu H; Liu J; Yang H; Wan S; Wang Y; Bao D
J Exp Clin Cancer Res; 2022 Feb; 41(1):76. PubMed ID: 35209954
[TBL] [Abstract][Full Text] [Related]
34. Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway.
Ma H; Kang Z; Foo TK; Shen Z; Xia B
Hepatology; 2023 Jan; 77(1):33-47. PubMed ID: 35006619
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms and cellular functions of cGAS-STING signalling.
Hopfner KP; Hornung V
Nat Rev Mol Cell Biol; 2020 Sep; 21(9):501-521. PubMed ID: 32424334
[TBL] [Abstract][Full Text] [Related]
36. The bidirectional roles of the cGAS-STING pathway in pain processing: Cellular and molecular mechanisms.
Hu Y; Chen Y; Liu T; Zhu C; Wan L; Yao W
Biomed Pharmacother; 2023 Jul; 163():114869. PubMed ID: 37182515
[TBL] [Abstract][Full Text] [Related]
37. Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma.
Takehara Y; Tamaki T; Mimura K; Saito K; Neupane P; Tada T; Watanabe Y; Hayase S; Saze Z; Yoshimoto Y; Sato H; Kono K; Suzuki Y
Anticancer Res; 2023 Oct; 43(10):4691-4700. PubMed ID: 37772585
[TBL] [Abstract][Full Text] [Related]
38. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract][Full Text] [Related]
39. Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma.
Murakami T; Shoji Y; Nishi T; Chang SC; Jachimowicz RD; Hoshimoto S; Ono S; Shiloh Y; Takeuchi H; Kitagawa Y; Hoon DSB; Bustos MA
Mol Oncol; 2021 Apr; 15(4):1069-1087. PubMed ID: 33605536
[TBL] [Abstract][Full Text] [Related]
40. Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment.
Wang X; Ling X; Wang C; Zhang J; Yang Y; Jiang H; Xin Y; Zhang L; Liang H; Fang C; Zheng D; Zhu J; Ma J
Cancer Immunol Immunother; 2023 Jun; 72(6):1619-1631. PubMed ID: 36583750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]